GB1551672A - Thienamycin derivatives - Google Patents

Thienamycin derivatives

Info

Publication number
GB1551672A
GB1551672A GB10479/77A GB1047977A GB1551672A GB 1551672 A GB1551672 A GB 1551672A GB 10479/77 A GB10479/77 A GB 10479/77A GB 1047977 A GB1047977 A GB 1047977A GB 1551672 A GB1551672 A GB 1551672A
Authority
GB
United Kingdom
Prior art keywords
thienamycin
toxic
pharmaceutically acceptable
acceptable salts
sulphoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB10479/77A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1551672A publication Critical patent/GB1551672A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Thienamycin sulphoxide of the structural formula I <IMAGE> and the non-toxic, pharmaceutically acceptable salts thereof are obtained by oxidising thienamycin and converting the resulting compound where appropriate into the non-toxic, pharmaceutically acceptable salts. Thienamycin sulphone and the non-toxic, pharmaceutically acceptable salts thereof are obtained by preparing thienamycin sulphoxide of the structural formula I, and further oxidising the resulting compound and converting the compound obtained in this way where appropriate into the non-toxic, pharmaceutically acceptable salts. The compounds which can be prepared according to the invention are generally valuable antibiotics which are active against various Gram-negative and Gram-positive bacteria.
GB10479/77A 1976-03-16 1977-03-11 Thienamycin derivatives Expired GB1551672A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66732376A 1976-03-16 1976-03-16

Publications (1)

Publication Number Publication Date
GB1551672A true GB1551672A (en) 1979-08-30

Family

ID=24677763

Family Applications (1)

Application Number Title Priority Date Filing Date
GB10479/77A Expired GB1551672A (en) 1976-03-16 1977-03-11 Thienamycin derivatives

Country Status (8)

Country Link
JP (1) JPS52111591A (en)
CH (1) CH630086A5 (en)
DE (1) DE2711223A1 (en)
DK (1) DK90277A (en)
FR (1) FR2344558A1 (en)
GB (1) GB1551672A (en)
NL (1) NL7702183A (en)
SE (1) SE7702370L (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1577725A (en) * 1976-06-30 1980-10-29 Beecham Group Ltd Azetidinone derivatives
EP0002564B1 (en) * 1977-11-12 1984-06-20 Beecham Group Plc Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
JPS61236785A (en) * 1985-04-15 1986-10-22 Sankyo Co Ltd Azetidinone derivative

Also Published As

Publication number Publication date
FR2344558A1 (en) 1977-10-14
DE2711223A1 (en) 1977-10-27
SE7702370L (en) 1977-09-17
CH630086A5 (en) 1982-05-28
JPS52111591A (en) 1977-09-19
NL7702183A (en) 1977-09-20
DK90277A (en) 1977-09-17
FR2344558B1 (en) 1980-06-13

Similar Documents

Publication Publication Date Title
AU565927B2 (en) Cephalosporin derivatives
EG15121A (en) Process for preparing of cephalosporin derivatives
GB1544872A (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
ES476109A1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions and their preparation.
GB1551672A (en) Thienamycin derivatives
IE780631L (en) Azabicycloheptenes
DE3470313D1 (en) Antibiotic, its preparation and its use
DE2963665D1 (en) Cephem derivatives, process for their preparation and pharmaceutical compositions containing them
IE44433L (en) Derivatives of thienamycin and its isomers
DE3375787D1 (en) Cephalosporin derivatives, methods of production thereof and prophylactic and therapeutic agents for bacterial infection
FR2435481B1 (en)
AU562643B2 (en) N-arylpiperazine derivatives
JPS57185292A (en) Cephem derivative and manufacture
SE8303727L (en) cephalosporin antibiotics
GB1539053A (en) Process for the preparation of alpha-(2-oxoimidazolidinyl carbonylamino)-acetamido cephalosporins

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee